Home > Boards > US OTC > Biotechs > NorthWest Biotherapeutics Inc. (NWBO)

All the information you'd like to see will

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
skitahoe Member Profile
 
Followed By 111
Posts 5,631
Boards Moderated 0
Alias Born 08/14/03
160x600 placeholder
Amended Current Report Filing (8-k/a) Edgar (US Regulatory) - 9/15/2020 5:14:31 PM
SA Breaking News: ALYI - Alternet Systems revenue surging with new potential customers InvestorsHub NewsWire - 9/14/2020 10:10:04 AM
Traders News Source Identifies Tomorrows NASDAQ's InvestorsHub NewsWire - 9/3/2020 8:45:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/1/2020 3:24:29 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/20/2020 4:52:41 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/10/2020 4:44:16 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 8/7/2020 5:27:35 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 6/26/2020 5:07:03 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 6/24/2020 6:02:25 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/8/2020 5:02:02 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/4/2020 5:12:40 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 5/29/2020 5:28:18 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/27/2020 5:15:15 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/20/2020 5:06:06 PM
Notification That Quarterly Report Will Be Submitted Late (nt 10-q) Edgar (US Regulatory) - 5/12/2020 4:12:38 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/23/2020 5:10:20 PM
Cannabis? CBD? That's Old News, A New Sector Bull Run Has Begun InvestorsHub NewsWire - 4/16/2020 8:00:00 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 4/9/2020 5:28:45 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/1/2020 4:41:56 PM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 3/27/2020 2:47:39 PM
Annual Report (10-k) Edgar (US Regulatory) - 3/16/2020 5:01:48 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 2/24/2020 5:07:15 PM
PURA ALERT - MACD Cross Pushing $0.039 50 Day MA With $0.35 Analyst TGT Recommendation InvestorsHub NewsWire - 2/10/2020 12:50:46 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 1/15/2020 4:54:03 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 1/3/2020 5:04:36 PM
skitahoe   Saturday, 06/27/20 01:50:12 PM
Re: trocprofit post# 292128
Post # of 311608 
All the information you'd like to see will be presented, but not in TLD. I would hope it will be seen here:

https://www.soc-neuro-onc.org/SNO/News/2020_SNO_Annual_Meeting.aspx

Hopefully they've submitted a placeholder abstract which will permit them to discuss the entire trial in depth. It's too early to say if this will be a real conference, or a virtual one, but I suspect it will become virtual as the date approaches unless miraculously a vaccine is available for Covid-19 well before it is scheduled to occur.

ASCO was virtual this year, I expect most others will be, if not they may be rescheduled, but frankly I believe that many are seeing benefits to virtual conferences and even after covid has disappeared, I wouldn't be surprised if conferences will have options, you may attend, or you may enroll virtually. My Dr. at City of Hope has attended many ASH and ASCO conferences, but I suspect that if he's not presenting, he'd choose the virtual option if available. While I think there is nothing like speaking directly with others in the field, I believe that people are learning they can express views in Zoom conferences, and they can be constructive.

It's after presentation of the data at SNO or other conference that the data you expect to see in TLD will become available to investors, as after such a conference, it is considered to be peer reviewed.

Gary

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences